In a phase 1 trial, Novo Nordisk's experimental obesity drug amycretin led to up to 13% weight loss in just three months.

Amjevita is a prescription drug used to treat certain inflammatory conditions. Learn about the common, mild, and serious side ...

If you’re taking finasteride — or the brand name versions Propecia or Proscar — you’re probably checking your hairline for ...

Researchers at Teesside University found incorrectly injecting dermal fillers are linked with potential toxicity, lymphatic ...

A next-generation obesity drug candidate from Novo Nordisk produced modest weight loss, along with a higher rate of some ...

Postpartum hemorrhage (PPH) is a serious condition where a woman experiences significant blood loss after giving birth. It ...